CurrentRheuma
Get Weekly

Topic · page 12 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 441–480 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Ann Rheum Dis

    CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion

    Mechanistic study

  2. Rheumatology (Oxford)

    Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis

    Cohort study

  3. Clin Exp Rheumatol

    Regenerative treatments for scleroderma in cutaneous manifestations of the face: a systematic review

    Meta-analysis

  4. Rheumatology (Oxford)

    Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis

    Secondary analysis

  5. Rheumatology (Oxford)

    Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis

    Cross-sectional study

  6. Clin Exp Rheumatol

    Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis

    Cross-sectional study

  7. Arthritis Care Res (Hoboken)

    Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity

    Cohort study

  8. Rheumatology (Oxford)

    Patients’ unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis

    Cross-sectional study

  9. Arthritis Care Res (Hoboken)

    A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis

    Cross-sectional study

  10. RMD Open

    Factors associated with satisfaction with social roles and activities among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study

    Cross-sectional study

  11. Rheumatology (Oxford)

    Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial

    Randomized controlled trial

  12. J Rheumatol

    Understanding the Employment Landscape in People With Systemic Sclerosis

    Cross-sectional study

  13. Arthritis Rheumatol

    Adeno‐Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis

    Mechanistic study

  14. Arthritis Care Res (Hoboken)

    Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity Scale

    Diagnostic or prognostic study

  15. Rheumatology (Oxford)

    Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis

    Cohort study

  16. Rheumatology (Oxford)

    Lung imaging patterns in connective tissue disease–associated interstitial lung disease impact prognosis and immunosuppression response

    Cohort study

  17. Rheumatology (Oxford)

    Fragmented QRS complex could predict all-cause mortality in patients with connective tissue disease–associated pulmonary arterial hypertension

    Cohort study

  18. Rheumatology (Oxford)

    Preliminary nomogram model for predicting irreversible organ damage of patients with systemic sclerosis

    Cohort study

  19. Semin Arthritis Rheum

    Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group

    Research article

  20. J Rheumatol

    Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography

    Diagnostic or prognostic study

  21. Joint Bone Spine

    High-resolution peripheral quantitative computed tomography for the assessment of acro-osteolysis and calcinosis in patients with systemic sclerosis

    Diagnostic or prognostic study

  22. Rheumatology (Oxford)

    Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosis

    Mechanistic study

  23. Rheumatology (Oxford)

    A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

    Randomized controlled trial

  24. Rheumatology (Oxford)

    Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome

    Mechanistic study

  25. Semin Arthritis Rheum

    Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications

    Cohort study

  26. Arthritis Res Ther

    Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray

    Research article

  27. J Rheumatol

    Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series

    Cohort study

  28. J Rheumatol

    Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease

    Cohort study

  29. Semin Arthritis Rheum

    Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial

    Secondary analysis

  30. Semin Arthritis Rheum

    KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)

    Cross-sectional study

  31. RMD Open

    Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets

    Cohort study

  32. Arthritis Care Res (Hoboken)

    Effects of a Resilience‐Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial

    Randomized controlled trial

  33. RMD Open

    Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort

    Cohort study

  34. Rheumatology (Oxford)

    Assessment of foot impairment in systemic sclerosis: a cross-sectional study

    Cross-sectional study

  35. RMD Open

    History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis

    Case-control study

  36. Arthritis Rheumatol

    Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis

    Mechanistic study

  37. Rheumatology (Oxford)

    Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisis

    Cross-sectional study

  38. Clin Exp Rheumatol

    Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis

    Meta-analysis

  39. Arthritis Care Res (Hoboken)

    Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Cohort study

  40. Arthritis Care Res (Hoboken)

    Impact of the COVID‐19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis

    Cross-sectional study

All 671 Briefs in ExploreShowing Briefs 441–480 of 671, newest first